Vimarsana
Biggest News Aggregation in the World

Page 29 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topline Today - Breaking & Trending Today

CNN New Day With John Berman and Brianna Keilar June 4, 2024 12:15:00 - Vimarsana News

CNN New Day With John Berman and Brianna Keilar June 4, 2024 12:15:00

We can do very good tactical things like kill a man, if we know where he is. but the strategic implications of what we can do in counterterrorism, building alliances, denying area to an enemy, knowing what their plans are, that has been massively hampered. let's celebrate this win. i'm glad he's dead. but let's go into this eyes wide open. you got to stay on the offense of the biggest terrorists. they have not changed their opinion. they haven't changed their mind. they still want to do what they did on 9/11. >> congressman kinzinger, it is great to have you this morning, thank you for being w...

Astellas, Seagen Report Positive Topline Results For Padcev With Keytruda To Treat Urothelial Cancer - Vimarsana News

Astellas, Seagen Report Positive Topline Results For Padcev With Keytruda To Treat Urothelial Cancer

KENILWORTH (NJ) (dpa-AFX) - Japan's Astellas Pharma Inc. (ALPMY, ALPMY) and Seagen Inc. (SGEN) announced Tuesday positive topline results from the EV-103 trial or Cohort K for Padcev (enfortumab

Humanigen, Inc. Receives Preliminary Topline Data from NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B - Vimarsana News

Humanigen, Inc. Receives Preliminary Topline Data from NIH/NIAID Study of Lenzilumab in ACTIV-5/BET-B

Humanigen, Inc. has been informed of preliminary topline results from the National Institute of Allergy and Infectious Diseases' ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus... | July 13, 2022

Cinedigm : Chairman's Letter to Cinedigm Shareholders Outlines Continued Positive Business Momentum Following Strong Performance in the Prior Fiscal Year - Vimarsana News

Cinedigm : Chairman's Letter to Cinedigm Shareholders Outlines Continued Positive Business Momentum Following Strong Performance in the Prior Fiscal Year

07/12/2022 DownloadPDF Company Expects to Achieve Significant Topline Growth, Sustainable Long-Term Profitability and Positive Cash Flow in Current... | July 12, 2022

Sun Valley Scene Day 2: Elon Musk Watch Begins, Rupert Murdoch and Mark Zuckerberg Lay Low - Vimarsana News

Sun Valley Scene Day 2: Elon Musk Watch Begins, Rupert Murdoch and Mark Zuckerberg Lay Low

SUN VALLEY, Idaho — The Elon Musk watch is on. The first full day of Allen &...